Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease
Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease: a Randomized, Single-blind, Crossover Clinical Study
Sponsor: First Affiliated Hospital of Harbin Medical University
Listed as NCT04001894, this PHASE4 trial focuses on Platelet Reactivity and remains completed. Sponsored by First Affiliated Hospital of Harbin Medical University, it has been updated 8 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Feb 2022 — Jul 2024 [monthly]
Completed PHASE4
-
Sep 2021 — Feb 2022 [monthly]
Completed PHASE4
-
Feb 2021 — Sep 2021 [monthly]
Completed PHASE4
Status: Recruiting → Completed
▶ Show 3 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE4
-
Aug 2019 — Jan 2021 [monthly]
Recruiting PHASE4
-
Jul 2019 — Aug 2019 [monthly]
Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- First Affiliated Hospital of Harbin Medical University
For direct contact, visit the study record on ClinicalTrials.gov .